Semanteon Capital Management LP Takes Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Semanteon Capital Management LP acquired a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPNFree Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 76,761 shares of the construction company’s stock, valued at approximately $1,211,000. Aspen Aerogels accounts for 0.8% of Semanteon Capital Management LP’s investment portfolio, making the stock its 25th largest position. Semanteon Capital Management LP owned about 0.11% of Aspen Aerogels at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. grew its position in Aspen Aerogels by 71.4% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company’s stock valued at $198,000 after acquiring an additional 9,601 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Aspen Aerogels by 38.5% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after acquiring an additional 3,607 shares during the period. Cornerstone Investment Partners LLC bought a new stake in Aspen Aerogels in the fourth quarter valued at $230,000. Raymond James Financial Services Advisors Inc. bought a new stake in Aspen Aerogels in the fourth quarter valued at $265,000. Finally, Mesirow Financial Investment Management Inc. bought a new stake in Aspen Aerogels in the third quarter valued at $334,000. 97.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have commented on the company. Canaccord Genuity Group boosted their price objective on Aspen Aerogels from $13.00 to $17.00 and gave the stock a “buy” rating in a research note on Wednesday, December 27th. Canaccord Genuity Group upped their price target on Aspen Aerogels from $13.00 to $17.00 and gave the company a “buy” rating in a research note on Wednesday, December 27th. TheStreet raised Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. HC Wainwright reaffirmed a “buy” rating and set a $20.00 price target on shares of Aspen Aerogels in a research note on Wednesday, February 14th. Finally, Roth Mkm began coverage on Aspen Aerogels in a research note on Wednesday, March 6th. They set a “buy” rating and a $22.00 price target on the stock. One investment analyst has rated the stock with a sell rating and five have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $19.00.

Get Our Latest Stock Analysis on ASPN

Aspen Aerogels Stock Down 5.6 %

Shares of NYSE:ASPN traded down $0.94 during mid-day trading on Thursday, reaching $15.70. 630,732 shares of the stock were exchanged, compared to its average volume of 959,763. The company has a quick ratio of 2.91, a current ratio of 3.41 and a debt-to-equity ratio of 0.24. The company has a market cap of $1.21 billion, a P/E ratio of -23.79 and a beta of 2.04. Aspen Aerogels, Inc. has a one year low of $5.32 and a one year high of $19.10. The stock’s 50 day simple moving average is $16.52 and its 200-day simple moving average is $13.25.

Aspen Aerogels (NYSE:ASPNGet Free Report) last issued its quarterly earnings results on Tuesday, February 13th. The construction company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative return on equity of 10.47% and a negative net margin of 19.19%. The firm had revenue of $84.22 million during the quarter, compared to analysts’ expectations of $83.82 million. During the same period in the prior year, the firm posted ($0.20) earnings per share. As a group, equities research analysts predict that Aspen Aerogels, Inc. will post -0.24 EPS for the current year.

Aspen Aerogels Company Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Recommended Stories

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.